Matches in Wikidata for { <http://www.wikidata.org/entity/Q72628928> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q72628928 description "article scientifique publié en 1993" @default.
- Q72628928 description "artículu científicu espublizáu n'agostu de 1993" @default.
- Q72628928 description "im August 1993 veröffentlichter wissenschaftlicher Artikel" @default.
- Q72628928 description "scientific article published on 01 August 1993" @default.
- Q72628928 description "wetenschappelijk artikel" @default.
- Q72628928 description "наукова стаття, опублікована в серпні 1993" @default.
- Q72628928 name "Immunoendocrine therapy with interleukin-2 (IL-2) and medroxyprogesterone acetate (MPA): a randomized study with or without MPA in metastatic renal cancer patients during IL-2 maintenance treatment after response or stable disease to IL-2 subcutaneo" @default.
- Q72628928 name "Immunoendocrine therapy with interleukin-2" @default.
- Q72628928 type Item @default.
- Q72628928 label "Immunoendocrine therapy with interleukin-2 (IL-2) and medroxyprogesterone acetate (MPA): a randomized study with or without MPA in metastatic renal cancer patients during IL-2 maintenance treatment after response or stable disease to IL-2 subcutaneo" @default.
- Q72628928 label "Immunoendocrine therapy with interleukin-2" @default.
- Q72628928 prefLabel "Immunoendocrine therapy with interleukin-2 (IL-2) and medroxyprogesterone acetate (MPA): a randomized study with or without MPA in metastatic renal cancer patients during IL-2 maintenance treatment after response or stable disease to IL-2 subcutaneo" @default.
- Q72628928 prefLabel "Immunoendocrine therapy with interleukin-2" @default.
- Q72628928 P1433 Q72628928-383C9010-BF07-495D-AD19-E3E5D89C759A @default.
- Q72628928 P1476 Q72628928-81CE70A0-2ED7-416F-91BF-BC309E0FEC78 @default.
- Q72628928 P2093 Q72628928-231237A2-8050-48FC-B87F-6F61395860D7 @default.
- Q72628928 P2093 Q72628928-53D987F8-C235-4646-96A9-1AF0512EE033 @default.
- Q72628928 P2093 Q72628928-7D9DC720-88DF-4530-9D5B-E65DE55048FE @default.
- Q72628928 P2093 Q72628928-84A15B7E-03E5-4DCC-AEF6-CB44CB9E77CD @default.
- Q72628928 P2093 Q72628928-9522E797-74A9-4349-9022-1F520F7DA984 @default.
- Q72628928 P2093 Q72628928-A7FCED7E-7D30-4AEF-AF4C-FC8536445FD8 @default.
- Q72628928 P2093 Q72628928-E144ECCA-31A3-4967-A4B7-1B8E6C9BFA1C @default.
- Q72628928 P2093 Q72628928-F7A04ADE-0249-4576-8DBE-B74813B86440 @default.
- Q72628928 P304 Q72628928-0C854DD2-FFBA-4713-B576-C5657C7B61B9 @default.
- Q72628928 P31 Q72628928-4088746C-405C-4B67-AEFE-B7C6EB34B584 @default.
- Q72628928 P356 Q72628928-9BA36DB0-E478-482A-BD93-1A559D3121E7 @default.
- Q72628928 P433 Q72628928-9693E334-6D50-4430-A9B7-84648D5C7849 @default.
- Q72628928 P478 Q72628928-9C253384-5107-4B85-B07A-3F0C85D23D22 @default.
- Q72628928 P577 Q72628928-1022139C-8312-46A4-9EA5-519ABCA44DFA @default.
- Q72628928 P698 Q72628928-F06339D7-6BE3-4D3F-9282-9196ABC8C83C @default.
- Q72628928 P921 Q72628928-8C8AB23E-B6B5-4A8C-BA5D-1C17708D8898 @default.
- Q72628928 P356 030089169307900403 @default.
- Q72628928 P698 8249176 @default.
- Q72628928 P1433 Q15757838 @default.
- Q72628928 P1476 "Immunoendocrine therapy with interleukin-2 (IL-2) and medroxyprogesterone acetate (MPA): a randomized study with or without MPA in metastatic renal cancer patients during IL-2 maintenance treatment after response or stable disease to IL-2 subcutaneous therapy" @default.
- Q72628928 P2093 "F Brivio" @default.
- Q72628928 P2093 "F Frigerio" @default.
- Q72628928 P2093 "G Tancini" @default.
- Q72628928 P2093 "M Vaghi" @default.
- Q72628928 P2093 "P Cardellini" @default.
- Q72628928 P2093 "P Lissoni" @default.
- Q72628928 P2093 "S Barni" @default.
- Q72628928 P2093 "V Fossati" @default.
- Q72628928 P304 "246-249" @default.
- Q72628928 P31 Q13442814 @default.
- Q72628928 P356 "10.1177/030089169307900403" @default.
- Q72628928 P433 "4" @default.
- Q72628928 P478 "79" @default.
- Q72628928 P577 "1993-08-01T00:00:00Z" @default.
- Q72628928 P698 "8249176" @default.
- Q72628928 P921 Q2823834 @default.